august 24 2025 glp-1 Two Years After Stopping GLP-1s, Most Patients Sustain at Least Some Weight Loss GLP-1s: The world's first longevity

At 80 years old, Jens continues to advance research in diabetes and obesity treatment, inspiring scientists across generations

Power Up and Reset: Berberine Patch &amp

Lively's HSA Spend Report shows consumers are increasingly using accounts for online wellness, mental health, and weight-loss products.

Recent observations and emerging research have raised concerns about increased tendon injuries and declining bone health in some individuals using GLP-1 therapies

Recently, SGLT2i and GLP1- RAs have emerged as potential therapeutic tools preventing the transition from acute to chronic kidney disease due to their efficacy in preserving renal function